Скачать с ютуб Researchers Identify EGLN2, a Potential Therapeutic Target for Amyotrophic Lateral Sclerosis (ALS) в хорошем качестве

Researchers Identify EGLN2, a Potential Therapeutic Target for Amyotrophic Lateral Sclerosis (ALS)

In this series, one of the authors of a recent neuroscience publication shares bite-sized summary of their latest research. In this video, Christine Germeys from the Ludo Van Den Bosch Lab of Neurobiology at the VIB-KU Center for Brain & Disease Research outlines the work conducted by herself and colleagues in the paper: "Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response" (Germeys et al. Cell Reports, 2024). To read an overview: https://cbd.sites.vib.be/en/news#/new... To read the full publication: https://www.cell.com/cell-reports/ful...